| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18161 R76385 |
Chan (Controls exposed to SSRIs), 2024 | Cardiac septal defect | 1st trimester | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: TCA only |
1.43 [0.66;3.06] C excluded (control group) |
10/322 21/956 | 31 | 322 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18156 R76339 |
Chan (Controls unexposed, general pop), 2024 | Cardiac septal defect | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) excluded | Adjustment: Yes Monotherapy: TCA only |
3.10 [1.50;6.40] excluded (control group) |
10/322 6,299/462,377 | 6,309 | 322 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18157 R76350 |
Chan (Controls unexposed, sick), 2024 | Cardiac septal defect | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes Monotherapy: TCA only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified | 0.66 [0.16;2.72] | 2/181 74/4,413 | 76 | 181 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11052 R40988 |
Bérard (Controls unexposed, sick), 2017 | Ventricular/atrial septal defect | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: Yes Monotherapy: TCA only Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 1.10 [0.54;2.24] | -/382 -/14,847 | - | 382 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10938 R40733 |
Ban (Controls unexposed, disease free), 2014 | Septal defects | 1st trimester | retrospective cohort (claims database) | unexposed, disease free | Adjustment: Yes Monotherapy: TCA only | 0.98 [0.55;1.73] | -/2,428 -/325,294 | - | 2,428 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11668 R42773 |
Källen, 2013 | Septum defects | early pregnancy | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.66 [1.17;2.35] | 31/2,139 -/- | - | 2,139 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10930 R40600 |
Davis, 2007 | Bulbus cordis anomalies and anomalies of cardiac septal closure | 1st trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 0.92 [0.23;3.70] | 2/167 680/49,669 | 682 | 167 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 5 studies | 1.31 [1.00;1.73] | 758 | 5,297 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, sick; 2: Controls unexposed, sick; 3: Controls unexposed, disease free;
Asymetry test p-value = 0.0792 (by Egger's regression)
slope=0.7110 (0.1853); intercept=-1.6049 (0.6133); t=2.6169; p=0.0792
excluded 18161, 18156